Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides

This publication has 9 references indexed in Scilit:

• The renaissance of erythromycin
  Journal of Antimicrobial Chemotherapy, 1986
• Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice
  Antimicrobial Agents and Chemotherapy, 1986
• Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro
  Antimicrobial Agents and Chemotherapy, 1986
• Effect of human serum on inhibition of growth ofStaphylococcus aureus by antimicrobial agents
  European Journal of Clinical Microbiology & Infectious Diseases, 1986
• Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum
  Antimicrobial Agents and Chemotherapy, 1986
• Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (First of Two Parts)
  Mayo Clinic Proceedings, 1985
• Erythromycin Uptake and Accumulation by Human Polymorphonuclear Leukocytes and Efficacy of Erythromycin in Killing Ingested Legionella pneumophila
  The Journal of Infectious Diseases, 1984
• In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs
  Antimicrobial Agents and Chemotherapy, 1983
• Standardization of a Preparative Ultracentrifuge Method for Quantitative Determination of Protein Binding of Seven Antibiotics
  The Journal of Infectious Diseases, 1977